Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Vor Biopharma Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 60
- +2 vs. Q3 2023
- Shares held
- 59.6M
- −235.2K (−0.4%) vs. Q3 2023
- Total value
- $134.1M
- +$7.25M (+5.7%) vs. Q3 2023
- New holders
- 7
- 21 more added
- Sold out
- 5
- 14 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 102 | $893.0M |
| Q1 2026 | 80 | $716.9M |
| Q4 2025 | 55 | $332.0M |
| Q3 2025 | 37 | $183.4M |
| Q2 2025 | 35 | $91.9M |
| Q1 2025 | 46 | $43.2M |
| Q4 2024 | 52 | $67.6M |
| Q3 2024 | 54 | $33.5M |
| Q2 2024 | 71 | $54.5M |
| Q1 2024 | 69 | $139.7M |
| Q4 2023 | 60 | $134.1M |
| Q3 2023 | 59 | $127.7M |
| Q2 2023 | 71 | $187.8M |
| Q1 2023 | 60 | $325.7M |
| Q4 2022 | 58 | $400.3M |
| Q3 2022 | 48 | $125.5M |
| Q2 2022 | 49 | $154.8M |
| Q1 2022 | 58 | $187.9M |
| Q4 2021 | 61 | $362.0M |
| Q3 2021 | 55 | $481.2M |
| Q2 2021 | 51 | $571.2M |
| Q1 2021 | 49 | $1.31B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Vor Biopharma Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 22,748,880 | $51.2M | 0.80% | 00.0% | Unchanged |
| FMR LLC | 7,618,948 | $17.1M | 0.00% | −32,228−0.4% | Reduced |
| Paradigm Biocapital Advisors LP | 6,457,293 | $14.5M | 0.68% | −4,174−0.1% | Reduced |
| 5AM Venture Management, LLC | 6,361,723 | $14.3M | 3.80% | 00.0% | Unchanged |
| Laurion Capital Management LP | 3,182,889 | $7.16M | 0.26% | 00.0% | Unchanged |
| Artal Group S.A. | 2,347,424 | $5.28M | 0.18% | −340,591−12.7% | Reduced |
| BlackRock Inc. | 2,251,411 | $5.07M | 0.00% | +144,542+6.9% | Added |
| Vanguard Group Inc | 1,743,463 | $3.92M | 0.00% | +27,017+1.6% | Added |
| Woodline Partners LP | 1,111,123 | $2.50M | 0.03% | 00.0% | Unchanged |
| Johnson & Johnson | 1,074,658 | $2.42M | 0.06% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 794,063 | $1.79M | 0.00% | +37,711+5.0% | Added |
| Sarissa Capital Management LP | 618,000 | $1.39M | 0.21% | 00.0% | Unchanged |
| State Street Corp | 608,007 | $1.37M | 0.00% | +2,100+0.3% | Added |
| Northern Trust Corp | 397,221 | $893.7K | 0.00% | +45,780+13.0% | Added |
| MAI Capital Management | 357,151 | $803.6K | 0.01% | +357,151 | New |
| Ensign Peak Advisors, Inc | 346,087 | $778.7K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 172,061 | $387.1K | 0.00% | +95,037+123.4% | Added |
| Bridgeway Capital Management, LLC | 162,700 | $366.1K | 0.01% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 108,209 | $243.5K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 103,918 | $233.8K | 0.00% | 00.0% | Unchanged |
| Trustees of Columbia University in the City of New York | 91,910 | $206.8K | 0.44% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 71,504 | $160.9K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 63,579 | $143.1K | 0.00% | +10,738+20.3% | Added |
| Exchange Traded Concepts, LLC | 60,170 | $135.4K | 0.00% | +15,258+34.0% | Added |
| Bollard Group LLC | 55,555 | $125.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 53,541 | $120.5K | 0.00% | +22,644+73.3% | Added |
| Barclays PLC | 52,080 | $117.2K | 0.00% | +44,857+621.0% | Added |
| Renaissance Technologies LLC | 51,600 | $116.0K | 0.00% | +15,100+41.4% | Added |
| LMR Partners LLP | 51,111 | $115.0K | 0.00% | +2,331+4.8% | Added |
| Rhumbline Advisers | 42,990 | $96.7K | 0.00% | −1,912−4.3% | Reduced |
| Goldman Sachs Group Inc | 38,336 | $86.3K | 0.00% | +12,774+50.0% | Added |
| UBS Group AG | 37,933 | $85.3K | 0.00% | +21,573+131.9% | Added |
| Deutsche Bank AG | 31,835 | $71.6K | 0.00% | +31,835 | New |
| Citadel Advisors LLC | 30,646 | $69.0K | 0.00% | +29,036+1,803.5% | Added |
| Bourgeon Capital Management LLC | 29,450 | $66.3K | 0.01% | +2,500+9.3% | Added |
| JPMorgan Chase & Co | 24,498 | $55.1K | 0.00% | −809−3.2% | Reduced |
| New York State Common Retirement Fund | 21,495 | $48.4K | 0.00% | −121−0.6% | Reduced |
| SG Americas Securities, LLC | 21,296 | $48.0K | 0.00% | +4,038+23.4% | Added |
| Dimensional Fund Advisors LP | 20,486 | $46.1K | 0.00% | −11,206−35.4% | Reduced |
| American International Group, Inc. | 18,727 | $42.1K | 0.00% | −76−0.4% | Reduced |
| Invesco Ltd. | 18,038 | $40.6K | 0.00% | +3,515+24.2% | Added |
| Chicago Partners Investment Group LLC | 17,320 | $40.5K | 0.00% | −676−3.8% | Reduced |
| Jane Street Group, LLC | 16,945 | $38.1K | 0.00% | +16,945 | New |
| Voya Investment Management LLC | 15,894 | $35.8K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 14,271 | $32.0K | 0.00% | +7,122+99.6% | Added |
| Grimes & Company, Inc. | 13,656 | $30.7K | 0.00% | −330−2.4% | Reduced |
| Wells Fargo & Company | 11,610 | $26.1K | 0.00% | +2,292+24.6% | Added |
| United Bank | 10,900 | $24.5K | 0.00% | +10,900 | New |
| Wexford Capital LP | 10,050 | $22.6K | 0.00% | +10,050 | New |
| Group One Trading, L.P. | 10,000 | $22.5K | 0.00% | +10,000 | New |
| California State Teachers Retirement System | 6,201 | $14.0K | 0.00% | −2,112−25.4% | Reduced |
| Citigroup Inc | 5,737 | $12.9K | 0.00% | +5,719+31,772.2% | Added |
| Tower Research Capital LLC (TRC) | 5,315 | $12.0K | 0.00% | −10,366−66.1% | Reduced |
| Legal & General Group Plc | 3,627 | $8.14K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 3,286 | $7.00K | 0.00% | −378−10.3% | Reduced |
| Ameritas Investment Partners, Inc. | 3,111 | $7.00K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 2,077 | $4.00K | 0.00% | −89−4.1% | Reduced |
| Simplex Trading, LLC | 797 | $1.00K | 0.00% | +797 | New |
| Eagle Bay Advisors LLC | 150 | $338 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 45 | $101 | 0.00% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −633,848−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −149,690−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −15,693−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −10,221−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −10,009−100.0% | Sold out |
| OUP Management Co., LLC | – | – | – | – | Not filed |